semaglutide death GLP-1 Drugs Lower Risk of by 44% in Obesity and Autoimmune Disease The FDA has issued a

The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis

Children with certain GSTM1-null genotypes may be less able to handle oxidative stress and more vulnerable to prenatal exposures like medications

Nature Communications , 2026

doi: 10.1038/s41380-022-01792-4 265 MeissnerWGRemyPGiordanaCMaltteDDerkinderenPAnheimMet al

Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) represents an emergent global threat which is straining worldwide healthcare capacity

One of the largest compounders canceled plans to produce an off-brand semaglutide pill under pressure from the FDA and Wegovys manufacturer, Novo Nordisk